Healthcare Realty Trust Incorporated (NYSE: HR) stock fell -1.98% on Friday to $25.70 against a previous-day closing price of $26.22. With 3.94 million shares changed hands, the volume of the stock remained lighter than its average volume of 8.36 million shares. During the session, the REIT – Healthcare Facilities company that operates in wider Real Estate sector, reached to the highest price of $26.38 whereas the lowest price it dropped to was $25.67. The 52-week range on HR shows that it touched its highest point at $29.07 and its lowest point at $22.14 during that stretch. It currently has a 1-year price target of $32.79. With its current market cap of 9.32 billion, HR has annualized dividend of $0.12 while the current yield stands at 0.45%. Beta for the stock currently stands at 0.65.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HR was up-trending over the past week, with a rise of 4.73%, but this was up by 6.81% over a month. Three-month performance surged to 2.75% while six-month performance fell -5.43%. The stock gained 8.31% in the past year, while it has lost -7.81% so far this year. A look at the trailing 12-month EPS for HR yields 0.42 with Next year EPS estimates of 0.46. For the next quarter, that number is 0.09. This implies an EPS growth rate of 84.20% for this year and 16.46% for next year. EPS is expected to grow by 10.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 6.00%.
Float and Shares Shorts:
At present, 228.98 million HR shares are outstanding with a float of 149.17 million shares on hand for trading. On Jul 14, 2022, short shares totaled 25.03 million, which was 16.51% higher than short shares on Jun 14, 2022. In addition to Mr. Todd J. Meredith as the firm’s Pres, CEO & Director, Mr. James Christopher Douglas serves as its Exec. VP & CFO.
Through their ownership of 60.27% of HR’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 0.00% of HR, in contrast to 0.00% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in HR with 0.00% of the stake, Cohen & Steers UK Ltd. holds 4,720 shares worth 4,720. A second-largest stockholder of HR, Olive Street Investment Advisers, holds 1,585 shares, controlling over 0.00% of the firm’s shares. Danske Bank A/S is the third largest shareholder in HR, holding 10,800 shares or 0.00% stake. With a 0.00% stake in HR, the Nationwide Mid Cap Market Index F is the largest stakeholder. A total of 126,148 shares are owned by the mutual fund manager. The Nationwide VIT – Mid Cap Index Fu, which owns about 0.00% of HR stock, is the second-largest Mutual Fund holder. It holds 198,445 shares valued at 0.0. Nationwide Bailard Cognitive Valu holds 0.00% of the stake in HR, owning 0 shares worth 0.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2022, HR reported revenue of $142.89M and operating income of $20.35M. It generated $42.23M net income for the quarter, which came to $84.86M over the last twelve months. The EBITDA in the recently reported quarter was $74.24M and diluted EPS was $0.28. EBITDA for the full year was $292.83M.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HR since 5 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With HR analysts setting a high price target of $35.00 and a low target of $27.00, the average target price over the next 12 months is $31.00. Based on these targets, HR could surge 36.19% to reach the target high and rise by 5.06% to reach the target low. Reaching the average price target will result in a growth of 20.62% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. HR will report FY 2022 earnings on 02/16/2023. Analysts have provided yearly estimates in a range of $0.24 being high and $0.02 being low. For HR, this leads to a yearly average estimate of $0.13. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Healthcare Realty Trust Incorporated surprised analysts by -$0.03 when it reported $0.08 EPS against a consensus estimate of $0.11. The surprise factor in the prior quarter was -$0.03. Based on analyst estimates, the high estimate for the next quarter is $0.07 and the low estimate is $0.07. The average estimate for the next quarter is thus $0.07.